---
title: "Focusing on Technology and Healthcare Sectors, 46 Hong Kong Stock Thematic Funds Launched This Year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283059671.md"
description: "As of April 16, 46 Hong Kong stock thematic funds have been launched this year, doubling the number from the same period last year. Currently, 11 Hong Kong stock thematic funds are being issued, with another 4 set to start soon. In terms of investment direction, technology and healthcare sectors have attracted significant attention, particularly the Hong Kong Connect Information Technology Thematic ETF and multiple medical thematic ETFs currently under issuance"
datetime: "2026-04-16T22:16:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283059671.md)
  - [en](https://longbridge.com/en/news/283059671.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283059671.md)
---

# Focusing on Technology and Healthcare Sectors, 46 Hong Kong Stock Thematic Funds Launched This Year

The Hong Kong stock market is becoming a key focus for fund companies: as of April 16, 46 Hong Kong stock thematic funds have been launched this year, doubling the number compared to the same period last year; currently, 11 Hong Kong stock thematic funds are under issuance, and another 4 have announced their share sale plans and are set to begin issuance shortly. From the perspective of product investment direction, the Hong Kong stock technology sector has garnered high attention. Among them, the Hwabao WP CSI HK Connect Information Technology Composite ETF has attracted layout by multiple top-tier fund companies. The Hong Kong stock healthcare sector has also received considerable attention. Currently, the E Fund CSI Hong Kong Connect Medical Treatment Thematic ETF Feeder Fund, Yinhe CSI Hong Kong Connect Medical Treatment Thematic ETF, and GF Hong Kong Connect Medical Innovation Select Mixed Fund are among those being issued. (Shanghai Securities News)

### Related Stocks

- [159137.CN](https://longbridge.com/en/quote/159137.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [520510.CN](https://longbridge.com/en/quote/520510.CN.md)
- [520840.CN](https://longbridge.com/en/quote/520840.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [159740.CN](https://longbridge.com/en/quote/159740.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [159131.CN](https://longbridge.com/en/quote/159131.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [520920.CN](https://longbridge.com/en/quote/520920.CN.md)
- [513130.CN](https://longbridge.com/en/quote/513130.CN.md)
- [03174.HK](https://longbridge.com/en/quote/03174.HK.md)
- [520850.CN](https://longbridge.com/en/quote/520850.CN.md)
- [03033.HK](https://longbridge.com/en/quote/03033.HK.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [513180.CN](https://longbridge.com/en/quote/513180.CN.md)
- [03032.HK](https://longbridge.com/en/quote/03032.HK.md)
- [159742.CN](https://longbridge.com/en/quote/159742.CN.md)
- [159770.CN](https://longbridge.com/en/quote/159770.CN.md)

## Related News & Research

- [RemeGen says SPDB wealth product disclosure delay stems from oversight, sets remedial steps](https://longbridge.com/en/news/286916188.md)
- [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md)
- [CF PharmTech files HKEX next-day return disclosing share repurchase at HKD 20.36](https://longbridge.com/en/news/286900953.md)
- [United Labs says China regulator clears TUL108 injection for clinical trial](https://longbridge.com/en/news/286902656.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)